🇪🇺 Zimura in European Union

Zimura (Zimura) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006153
  • Marketing authorisation holder: Astellas Pharma Europe B.V.
  • Local brand name: Izelvay
  • Indication: Indicated for the treatment of adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
  • Status: withdrawn

Read official source →

Other Other approved in European Union

Frequently asked questions

Is Zimura approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Zimura in European Union?

Astellas Pharma Europe B.V. holds the EU marketing authorisation.